U.S. SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 10-QSB

        [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES
                              EXCHANGE ACT OF 1934

                  For the quarterly period ended: June 30, 2000

        [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT

                           Commission File No. 0-11808

                             MB SOFTWARE CORPORATION

                  Colorado                                      59-2219994
      (State or other jurisdiction of                        (I.R.S. Employer
       incorporation or organization)                     Identification Number)

                      2225 E. Randol Mill Road - Suite 305
                           Arlington, Texas 76011-6306
                                 (817) 633-9400

           Securities registered pursuant to Section 12(b) of the Act:


                                                     Name of each Exchange
         Title of Each Class                         on Which Registered
         -------------------                         -------------------
               Common                               NASDAQ - OTC BULLETIN BOARD

Check  whether the Issuer (1) filed all reports  required to be filed by Section
13 or 15(d) of the Securities Exchange Act of 1934 during the past 12 months (or
for shorter period that the  registrant was required to file such reports),  and
(2) has been subject to such filing requirements for the past 90 days.
                        Yes [X]               No [ ]


Check whether the  registrant  filed all  documents  and reports  required to be
filed by Section 12, 13 or 15(d) of the Exchange Act after the  distribution  of
securities under a plan confirmed by a court.
                        Yes [X]               No [ ]


As of July 31, 2000,  69,200,000  shares of the Issuer's  $.001 par value common
stock were outstanding.

Transitional Small Business Disclosure Format

                        Yes [ ]               No [X]



<PAGE>




                             MB SOFTWARE CORPORATION

                                   Form 10-QSB

                           Quarter Ended June 30, 2000

                                      INDEX

PART I  -  FINANCIAL INFORMATION                                     PAGE NUMBER

         Item 1  -  Financial Statements

            Consolidated Balance Sheet
            June 30, 2000 (Unaudited) and December 31, 1999                F1-F2

            Consolidated Statements of Operations  -
            for the Three Months and Six Months ended June 30, 2000
            (Unaudited) and  June 30, 1999 (Unaudited)                        F3

            Consolidated Statements of Cash Flows
            for the Three Months ended June 30, 2000 (Unaudited)
            and June 30, 1999 (Unaudited)                                     F4

            Notes to Consolidated Financial Statements                         4

         Item 2  -  Management's Discussion
         and Analysis of Financial Condition and
         Results of Operations                                             4,5,6

PART II - OTHER  INFORMATION

         Item 5  -  Other Information                                        6,7


         Item 6  -  Exhibits, Financial Statement Schedules
         and Reports on Form 8-K                                             7,8

SIGNATURES                                                                     8






<PAGE>

<TABLE>

<CAPTION>


                    MB SOFTWARE CORPORATION AND SUBSIDIARIES

                           CONSOLIDATED BALANCE SHEETS

                                     ASSETS
                                     ------

                                                                June 30,   December 31,
                                                                  2000         1999
                                                               ----------   ----------
                                                               (Unaudited)   (Audited)
<S>                                                            <C>          <C>
       Cash                                                    $   36,085   $   26,078

       Medical receivables, net allowance
             for doubtful accounts and contactual
             allowances of $972,689 and $822,692 in 2000 and
             1999, respectively                                   679,331      713,625
       Notes receivable                                           222,827      177,721
       Prepaid expenses                                             9,420        4,131
                                                               ----------   ----------

                    Total current assets                          947,663      921,555
                                                               ----------   ----------


PROPERTY AND EQUIPMENT, NET                                       149,900      178,525
                                                               ----------   ----------

       Note receivable - shareholder                              350,000      350,000
                                                               ----------   ----------

                  Total assets                                 $1,447,563   $1,450,080
                                                               ==========   ==========
</TABLE>




                                       F1

<PAGE>

<TABLE>

<CAPTION>


                    MB SOFTWARE CORPORATION AND SUBSIDIARIES

                           CONSOLIDATED BALANCE SHEETS



                      LIABILITIES AND SHAREHOLDERS' DEFICIT

                                                                     June 30,     December 31,
                                                                       2000          1999
                                                                   -----------   -----------
                                                                   (Unaudited)    (Audited)
<S>                                                                <C>            <C>
CURRENT LIABILITIES
  Current maturities of notes payable                              $ 1,453,070    $ 1,057,925
  Current maturities of capital leases                                   5,046         17,434
  Accounts payable                                                     319,434        402,410
  Accrued liabilities                                                  403,122        346,639
                                                                   -----------    -----------

         Total current liabilities                                   2,180,672      1,824,408


LONG TERM DEBT
       Capital leases                                                    3,050          3,050
                                                                   -----------    -----------

         Total long term liabilities                                     3,050          3,050
                                                                   -----------    -----------

         TOTAL LIABILITIES                                           2,183,722      1,827,458

SHAREHOLDERS' DEFICIT
  Series A senior cumulative  convertible particpating  preferred
    stock;  $10 par value; 340,000 shares issued and outstanding
    in 2000 and 1999; dividends in arrears 2000 $555,644, and ..     3,400,000      3,400,000
    1999, $385,644
  Undesignated preferred stock; $10 par value; 660,000 shares
    authorized; none issued                                               --             --
    Common stock .001 par value;150,000,000 shares
     authorized; 69,200,000 shares issued in 2000 and 1999              69,200         69,200
    Additional paid-in capital                                       1,103,005      1,103,005
    Accumulated deficit                                             (5,296,325)    (4,937,544)
    Treasury stock, at cost; 408,029 shares                            (12,039)       (12,039)
                                                                   -----------    -----------

         Total shareholders' deficit                                  (736,159)      (377,378)
                                                                   -----------    -----------

                                                                   $ 1,447,563    $ 1,450,080
                                                                   ===========    ===========
</TABLE>




                                       F2

<PAGE>

<TABLE>

<CAPTION>


                    MB SOFTWARE CORPORATION AND SUBSIDIARIES

                     CONSOLIDATED STATEMENTS OF OPERATIONS

                                   UNAUDITED



                                                                     Three Months End                 Six Months End
                                                               -----------------------------   ----------------------------
                                                               June 30, 2000   June 30, 1999   June 30, 2000   June 30,1999
                                                               -------------   -------------   -------------   ------------
<S>                                                            <C>             <C>             <C>             <C>
REVENUES
       Medical income - net of contractual
          Adjustments of $365,800 and $319,287 and $727,622
         and $631,861 in 2000 and 1999, respectively           $    416,146    $    590,193    $  1,105,071    $  1,097,655
       Service fees                                                     123          10,557             259          91,796
                                                               ------------    ------------    ------------    ------------

               Total revenues                                       416,269         600,750       1,105,330       1,189,451

COST OF REVENUES
       Cost of medical services                                     402,182         361,926         794,874         642,383
                                                               ------------    ------------    ------------    ------------

               Total cost of revenues                               402,182         361,926         794,874         642,383
                                                               ------------    ------------    ------------    ------------

GROSS PROFIT                                                         14,087         238,824         310,456         547,068

OPERATING EXPENSES
       Selling, general & administrative                            311,350         332,126         599,651         824,477
       Depreciation and amortization                                 14,921          20,590          28,625          37,603
                                                               ------------    ------------    ------------    ------------

               Total operating expenses                             326,271         352,716         628,276         862,080
                                                               ------------    ------------    ------------    ------------

LOSS FROM OPERATIONS                                               (312,184)       (113,892)       (317,820)       (315,012)

OTHER INCOME (EXPENSE)
       Interest income and other                                      8,744           2,223          19,288           5,987
       Interest Expense                                             (29,328)        (14,318)        (60,249)        (58,261)
                                                               ------------    ------------    ------------    ------------

               Total other income (expense)                         (20,584)        (12,095)        (40,961)        (52,274)
                                                               ------------    ------------    ------------    ------------

LOSS FROM CONTINUING OPERATIONS                                    (332,768)       (125,987)       (358,781)       (367,286)

DISCONTINUTED OPERATIONS
    Income (loss) from operations of discontinued subsidiary           --            (2,364)           --             7,351
                                                               ------------    ------------    ------------    ------------

             NET LOSS                                          $   (332,768)   $   (128,351)   $   (358,781)   $   (359,935)
                                                               ============    ============    ============    ============

Loss from continuing operations                                $   (332,768)   $   (125,987)   $   (358,781)   $   (367,286)


Plus: Cumulative preferred stock dividends                          (85,000)        (85,000)       (170,000)       (170,000)
                                                               ------------    ------------    ------------    ------------

            Loss available to common shareholders              $   (417,768)   $   (210,987)   $   (528,781)   $   (537,286)
                                                               ============    ============    ============    ============


BASIC AND DILUTED EARNINGS (L0SS) PER SHARE
   Continuing Operations                                       $       --      $       --      $       --              --
   Discontinued Operations                                             --              --              --              --
                                                               ------------    ------------    ------------    ------------

  Weighted-average common shares outstanding                     69,200,000      69,100,000      69,200,000      69,100,000
                                                               ============    ============    ============    ============
</TABLE>



                                       F3

<PAGE>

<TABLE>

<CAPTION>


                    MB SOFTWARE CORPORATION AND SUBSIDIARIES

                      CONSOLIDATED STATEMENTS OF CASH FLOWS

                                                                   SIX MONTHS      SIX MONTHS
                                                                      ENDED          ENDED
                                                                  June 30, 2000  June 30, 1999
                                                                  -------------  -------------
<S>                                                                <C>            <C>
CASH FLOWS FROM OPERATING ACTIVITIES
       Net loss from continuing operations                         $  (358,781)   $  (359,935)
       Adjustments to reconcile net loss from continuing
        operations to cash used by operating activities:
                    Depreciation                                        28,625         37,603
                    Change in allowance for doubtfull accounts .          --       (1,248,968)
                    Changes in assets and liabilities:
                          Accounts receivable                           34,294      1,713,392
                          Prepaid expenses                              (5,290)        (1,500)
                          Accounts payable                             (82,975)       (72,675)
                          Accrued liabilities                           56,484        (68,748)
                                                                   -----------    -----------

Net cash used in continuing operations                                (327,643)          (831)

Net cash used in discontinued operations                                  --         (111,960)
                                                                   -----------    -----------

Net cash used in operating activities                                 (327,643)      (112,791)
                                                                   -----------    -----------

CASH FLOWS FROM INVESTING ACTIVITIES
     Purchases of property and equipment                                  --          (47,177)
     Issuance of preferred stock dividends                                --          215,644
     Proceeds from sale of business segment                               --          302,745
     Payments on notes receivable                                       44,893           --
     Issuance of notes receivable                                      (90,000)      (172,174)
                                                                   -----------    -----------

Net cash provided by (used in) investing activities                    (45,107)       299,038

CASH FLOWS FROM FINANCING ACTIVITIES
     Payments on capital leases                                        (16,243)       (35,709)
     Payments on notes payable                                            --         (206,610)
     Proceeds from new borrowings                                      300,000        119,388
     Proceeds from notes payable related parties                        99,000         10,000
                                                                   -----------    -----------

Net cash provided by (used in) financing activities                    382,757       (112,931)
                                                                   -----------    -----------

NET INCREASE IN CASH                                                    10,007         73,316

 Cash at beginning of period                                            26,078        203,977
                                                                   -----------    -----------

 Cash at end of period                                             $    36,085    $   277,293
                                                                   ===========    ===========

SUPPLEMENTAL INFORMATION
       Cash paid during the period for interest to relate$ party          --      $    24,225
       Cash paid during the period for interest to others               30,920         49,427
                                                                   -----------    -----------

                                                                   $    30,920    $    73,652
                                                                   ===========    ===========
</TABLE>

                                       F4



<PAGE>

NOTE 1: BASIS OF PRESENTATION

The accompanying  unaudited consolidated financial statements have been prepared
in  accordance  with  generally  accepted  accounting   principles  for  interim
financial information and with the instructions to Form 10-QSB and Rule 10-01 of
Regulation  S-X.  They do not  include  all  information  and notes  required by
generally  accepted  accounting  principles for complete  financial  statements.
However,  except  as  disclosed,  there  has  been  no  material  change  in the
information disclosed in the notes to consolidated financial statements included
in the Annual  Report on Form  10-KSB of MB  Software  Corporation  for the year
ended  December  31,  1999.  In  the  opinion  of  management,  all  adjustments
(consisting  of  normal  recurring  accruals)  considered  necessary  for a fair
presentation  have been  included.  Operating  results for the six-month  period
ended June 30, 2000, are not  necessarily  indicative of the results that may be
expected for the year ending December 31, 2000.


NOTE 2:  ORGANIZATION AND NATURE OF OPERATIONS

The financial  statements  have been prepared on a going  concern  basis,  which
contemplates  realization  of  assets  and  liquidation  of  liabilities  in the
ordinary course of business.  The Company has continuously  incurred losses from
operations and has a working capital deficit.  The  appropriateness of using the
going concern basis is dependent upon the Company's ability to obtain additional
financing or equity capital and, ultimately,  to achieve profitable  operations.
These  conditions  raise  substantial  doubt  about its ability to continue as a
going  concern.  The financial  statements do not include any  adjustments  that
might result from the outcome of this uncertainty.

Management plans to raise capital by obtaining  financing through debt,  private
placement or conversion of Series A preferred  stock.  The Company believes that
these actions will enable the Company to continue  until its  operations  become
profitable.


NOTE 3:  RELATED PARTIES

Included in notes payable is related party payables of $224,000 and $889,000 for
2000 and 1999, respectively.

ITEM 2. MANAGEMENT'S  DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
OF OPERATIONS

General
-------

In the second quarter of 2000, MB Software  Corporation (the "Company")  focused
on the operations of its four  healthcare  clinics  consistent  with its overall
strategy to increase revenue.

The  strategy of the  Company  consists of a four point  approach  involving:  A
comprehensive pain management  program,  a controlled  increase in the number of
clinics in which the Company has a vested  interest,  contracting with insurance
companies  for   "total-episode   responsibility"   and  the   incorporation  of
leading-edge  healthcare  information  technology.  (See  discussion  at  Item 5
pertaining to Company strategy and developments).

There were no changes in the legal  proceedings from the status set forth in the
Form 10 - KSB for the year ending December 31, 1999.

The following  summarizes the results of operations for the  three-month and the
six-month period ended June 30, 2000 and 1999.

Three Months Ended June 30, 2000 Compared to Three Months Ended June 30, 1999
-----------------------------------------------------------------------------

Net  revenues  from  medical  activities  decreased  41.8% to  $416,146  for the
three-months  ended June 30,  2000,  compared to $590,193  for the  three-months
ended June 30, 1999.

A contractual  allowance  adjustment  of $365,800 was made for the  three-months
ended June 30, 2000,  compared to $319,287 for the  three-months  ended June 30,
1999. The Company follows the generally  accepted practice in medical clinics of
having in place  contracts  with  numerous  insurance  companies to better serve
patients.  These  contracts  establish  reimbursement  guidelines that result in
payment to the provider of only a portion of the account charge.  The balance of
the account charge is reduced from the revenue as a contractual  allowance.  The
increased contractual allowance is attributable,  in part to an increased number
of carriers  forming  alliances  with  managed care  organizations  resulting in
reduced  reimbursement to providers.  To address this reduction,  the Company is
pursuing more lucrative carrier  arrangements.  The Company additionally intends
to provide services to an increased number of patients on a self-pay basis.



                                       3


<PAGE>

The cost of medical  revenues  increased  11.1% to $402,182 for the three months
ended June 30,  2000,  compared to $361,926  for the three months ended June 30,
1999. This minimal increase is applicable to increases in certain pharmaceutical
supplies used in the clinics.

The gross profits from medical  activities  decreased  1,595% to $14,087 for the
three months  ended June 30, 2000,  as compared to $238,824 for the three months
ended June 30, 1999. This decrease  correlates with the current quarter increase
in the  contractual  allowances  together  with the  increased  cost of  medical
revenues.

The Company's selling,  general and administrative expenses decreased by 6.7% to
$311,350  for the three  months  ended June 30, 2000 as compared to $332,126 for
the three months ending June 30, 1999. This decrease  reflects savings resulting
from reductions of certain costs at the corporate level.

The net loss on  operations  was  $312,184 for the three month period ended June
30, 2000  representing  a 174.1%  difference  compared to $113,892 for the three
months  ended June 30,  1999.  This  percentage  reflects  the decrease in gross
profits.

Six Months Ended June 30, 2000 Compared to Six Months Ended June 30, 1999
-------------------------------------------------------------------------

The net medical revenues  increased 0.07% to $1,105,071 for the six-month period
ended June 30, 2000,  compared to $1,097,655 for the six-month period ended June
30, 1999. The minimal increase is attributable to net medical revenue  increases
during the first quarter of 2000.

The cost of medical revenue increased 23.7% to $794,874 for the six-month period
ended June 30, 2000, as compared to $642,383 for the six-month period ended June
30,  1999.   The  overall   increase  is  applicable   to  increased   costs  of
pharmaceutical  supplies during the second quarter of 2000 together with minimal
costs of supplies during the second quarter of June, 1999.

Gross  profit  decreased  to $310,456  for the six months  ended June 30,  2000,
compared to $547,068  for the six months  ended June 30,  1999.  The decrease in
gross profit is  attributable,  in part to a $91,537  reduction in service fees,
the increase in contractual allowances during the second quarter of 2000 and the
increased cost of revenues.

The Company's selling, general and administrative expenses decreased by 37.5% to
$599,651 for the six-months ending June 30, 2000 as compared to $824,477 for the
six months ending June 30, 1999. This decrease  reflects savings  resulting from
operational efficiency.

Net operating  loss increased  0.08% to $317,820 for the six-month  period ended
June 30, 2000, as compared to $315,012 for the  six-month  period ended June 30,
1999.  The minimal  variation  may be  accounted  for by noting that while gross
profits for the current second quarter  decreased,  the decrease was offset by a
substantial reduction in operating expenses.

Liquidity and Capital Resources
-------------------------------

The Company's  operations  used $10,007 of cash during the six months ended June
30, 2000  compared to a use of cash of $73,316 for the six months ended June 30,
1999.

As of June 30, 2000,  the Company had a working  capital  deficit of $1,233,009,
which is a 36.5%  increase  over the June 30, 1999  working  capital  deficit of
$902,853.  The  increase  in the  deficit  results  from the  December  31, 1999
maturity of long term debt.

As of June 30,  2000,  the  Company had cash of  $36,085.  To increase  its cash
position,  the Company is seeking to convert existing matured debt to manageable
long term financing.


                                       4


<PAGE>


PART II  - OTHER INFORMATION

ITEM 5.  OTHER INFORMATION

The strategy of the Company  continues to be the creation of a national physical
medicine network by utilizing a four point approach  consisting of:  Development
and  implementation  of a comprehensive  pain management and prevention  program
including nutritional supplements; increasing the number of clinics in which the
Company has an interest,  either through the means of acquisition,  ground-floor
development,  or innovative partnering  arrangements;  contracting with insurers
for "total-episode  responsibility;" and, most significantly,  the incorporation
of leading-edge information technology within the healthcare sector.

PatientMed 2000
Medical  information  technology is the cornerstone of the Company's strategy to
increase revenue. The technology  incorporates two independent yet complementary
facets:  An  Internet-based  comprehensive  healthcare  system  operated  on the
Company's ISP and, PatientMed 2000, a leading edge Internet appliance.

Effective   July  20,  2000,   the  Company   entered  into  an  agreement  with
ScreenPhone.net  Inc.  whereby the  Company  acquired  an  exclusive  license in
connection with PatientMed 2000.  Terms of the License  Agreement  include,  the
issuance to ScreenPhone of 1,000,000  shares of MB Software  Corporation  common
stock and the payment of royalties  by MB Software  Corporation  to  ScreenPhone
based on the revenues generated by MB Software Corporation.

PatientMed  2000 is a  screenphone  - an  appliance  incorporating  a telephone,
alphanumeric   keyboard,   modem  and  touch  screen,   to  provide  users  with
telephone-based   Internet  access.  The  standard  features  of  this  Internet
appliance  include  one-button-access  to  email  and  all  Internet  functions,
dual-line  capacity,  a built-in Web browser, a user friendly color touch-screen
navigation system,  speaker phone, caller ID, memory and speed dial, credit card
reader,  long distance service,  tasking capability,  calendar options,  address
features and a printer port.  PatientMed  2000  provides  users with an expanded
array of Internet and telephone  services as well as extensive  applications and
service packages specifically tailored to each segment of the healthcare market.

PatientMed 2000 facilitates a two-way mode of  communication  and an information
delivery  system between the physician and the patient.  By touching one icon on
the  screen,  the  patient  is  immediately  connected  to  the  Internet.  Once
connected,  the  patient  may  "chat"  on-line  with  the  physician  or  access
information via a secure email address provided to each patient.  In a real-time
communication  dynamic,  clinical data may be transmitted  and  assessments  and
interventions  made without the necessity of a patient office visit.  Similarly,
the patient may access the clinic email address to schedule appointments, obtain
certain lab  results,  order  clinic  nutritional  products  and obtain  medical
information and services directly related to the Company clinics.

Significantly,  PatientMed 2000 affords the clinic heretofore-unavailable direct
access to insurance companies.  The clinic may use PatientMed 2000 to access and
provide  insurance   information  in  two-way  real-time   communications   with
participating online insurance companies. This insurance function, together with
other administrative features,  should facilitate workflow automation,  increase
productivity and improve cash flow.

There is a three-fold  market for the  PatientMed  2000.  The prototypes for the
PatientMed  2000 will be utilized  in all  operational  venues in the  Company's
clinics.  This will afford the Company the substantial benefit of evaluating and
further enhancing PatientMed 2000 in its intended environment. The second market
for the  PatientMed  2000  includes  medical  clinics and  ancillary  healthcare
facilities  throughout  North America.  Patient and other  individual and entity
users comprise the third market.

The growth  potential in the second and third markets appears to be substantial.
According to IDC, a division of  International  Data Group,  in their report The
Worldwide  Information  Appliance  Market  1999-2004,  the author  projects that
worldwide Internet  appliance  shipments will grow from 11 million units in 1999
to over 89 million  units in 2004.  According  to an analyst for IDC's  Consumer
Devices research program:

         Current  online  users want access to services  in more  locations  and
         situations,  while many other consumers  desire Internet access without
         the inherent  complexities  of PC's. It is clear the PC will not be the
         only  enabling  device as both groups  find  information  appliances  a
         solution that can improve their lifestyle and work style.

IDC  predicts  that US unit  shipments  of  lower-cost,  transportable  consumer
information appliances will outnumber those of consumer PC's by 2002.



                                       5


<PAGE>

Concerning the costs for Internet appliances, the IDC anticipates that while the
costs for Internet appliances are expected to begin to drop significantly as the
market matures,  the worldwide value of Internet  appliance  shipments will grow
from $2.4 billion in 1999 to more than $17.8 billion in 2004.

Company Focus

The Company's four-point approach incorporates development and implementation of
a comprehensive  pain management and prevention  program.  The Company's premise
for this goal is providing superior pain management care to its patients through
utilization  of  standardized  "best  practice  outcomes"  or clinical  pathways
established  throughout  the Company and consistent  with accepted  standards of
medical practice.  This will include a complementary  nutritional products line.
Currently,  a  significant  number  of  individuals  in the  United  States  are
concerned with injury prevention.  A substantial number of patients include baby
boomers,  a  unique  group of  individuals  with  the  resources  and need for a
comprehensive  pain management and prevention  program of the type envisioned by
the Company.  There is also a robust  consumer  market in the United  States for
fitness-related  services  including  those  attendant to injury  prevention and
nutritional supplements.

The nexus of the four  points  focuses  on  increasing  the number of clinics in
which the Company has a qualitative as well as financial interest. To expand the
Company's  clinic base,  the Company  intends to utilize  innovative  partnering
arrangements.  The Company will only partner with  professionals  that share the
Company's vision of providing superior service and experience to patients.  This
will include medical doctors, osteopaths and chiropractors. The Company may also
consider  acquisition of existing clinics and the controlled  development of new
practices in selected cities.

The final strategy point forms the Company's economic  cornerstone.  The Company
will develop strategic  partnerships with insurers in which the  Company-managed
clinicians  will be granted  clinical  and  financial  responsibility  for total
episodic  care.  The Company  currently  has  structured an alliance with United
Healthcare,  a major  healthcare  force in markets  wherein the Company  clinics
transact business. As a product of the alliance, the Company acquired one of the
few  Pre-Approved  Pain  Management  care  contract  in the United  States.  For
episodes such as low-risk,  spinal-related  injury,  the Company clinicians will
receive  global  payments  covering  not only  professional  services,  but also
facility and ancillary care. This arrangement will enable clinicians to share in
the  healthcare  and economic  value created by improving care across the entire
spectrum of services.

With this four-point  strategy,  the Company will continue to build a nationwide
organization providing superior healthcare services for its customers as well as
economic value for its shareholders.

ITEM 6.  EXHIBITS, FINANCIAL STATEMENT SCHEDULES
              AND REPORTS ON FORM 8-K

Exhibits - All exhibits are  incorporated  by reference  from prior filings with
--------   the Commission.

Financial  Statements  - See Item 1 for  financial  statements  filed  with this
---------------------     report.

Reports on Form 8-K  - Filed 8-K on August 2, 2000
-------------------


--------------------------------------------------------------------------------
                                   SIGNATURES

In accordance  with the  requirements  of the Exchange Act, the  registrant  has
caused this report to be signed on its behalf by the undersigned  thereunto duly
authorized.

                                         MB SOFTWARE CORPORATION



Date: August 14, 1999                    /s/ Scott A. Haire
                                         ----------------------
                                         Scott A. Haire, Chairman of the Board,
                                         Chief Executive Officer and President
                                         (Principal Financial Officer)




                                       6